Are there any patient assistance programs for keytruda?

Are there patient assistance programs for Keytruda?

Merck offers a program called Merck Access Program that helps eligible patients afford Keytruda. The program provides assistance based on financial need and insurance coverage.

What does the Merck Access Program cover?

The program covers co-pay assistance for patients with commercial insurance and provides the drug at no cost for eligible uninsured patients. It also offers support for navigating insurance claims and prior authorizations.

How do patients qualify?

Eligibility depends on U.S. residency, diagnosis of an approved indication, and financial criteria that include income limits and insurance status. U.S. residents with an FDA-approved indication for Keytruda are eligible.

What alternatives exist if this program does not fit?

CancerCare and Patient Advocate Foundation run separate assistance programs that provide financial aid and case management for cancer patients taking immunotherapy drugs like Keytruda.

When does Keytruda’s patent expire?

Keytruda has basic patents that expire in 2028, with additional method-of-use patents extending protection through 2032.